跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,556 条关于
“IGT-303”
全部
7,556
临床试验
3,862
药物
2,893
机构
24
资讯
777
3个月前
Ingenia Therapeutics Receives KRX Approval for IPO as TIE2-Targeted Therapies Advance to Phase 3
去年
Coya Therapeutics' COYA 303 Demonstrates Anti-Inflammatory Effects in Preclinical Alzheimer's Model
去年
Myeloid Therapeutics' MT-303, a Novel mRNA CAR Therapy, Enters Phase 1 Trial for Liver Cancer
去年
Formosa Pharma's CPN-303 (APP13007) Achieves Positive Phase 3 Results in China for Post-Cataract Surgery Inflammation and Pain
去年
FDA Approves Retifanlimab Plus Carboplatin/Paclitaxel for Advanced Anal Cancer Following PODIUM-303 Trial Success
去年
SparX to Present Phase 1 Data on Novel Dual Checkpoint Inhibitor SPX-303 at AACR 2025
10天前
Coya Therapeutics Publishes Preclinical Data Showing Complementary Immunomodulatory Effects of COYA 303 in Neuroinflammation Model
9个月前
CREATE Medicines Initiates First-in-Class Frontline HCC Trial Combining In Vivo CAR Therapy MT-303 with Standard Immunotherapy
去年
NAYA Biosciences Initiates Phase 1/2a Trial of NY-303 for Hepatocellular Carcinoma
去年
NAYA Biosciences Initiates Phase 1/2a Trial of NY-303 for Hepatocellular Carcinoma
第 1 页,共 78 页
上一页
下一页